EUVIMEDEUVIMED entdecken
Crossref

The impact of Melissa officinalis L. leaf extract CPSP-02 on gastrointestinal motility: Segmentspecific responses in a mouse model

A Abot, N Pomié, L Berthomier, C Cotte, V Bardot, I Guinobert, C Blondeau, S Holowacz, C Knauf

Planta Medica · 01.03.2026 · 92 (03) · 241

DOI: 10.1055/s-0045-1814974 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von A Abot und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal motility disorders are found in a wide range of pathologies (spasms, stress, type 2 diabetes, irritable bowel syndrome, etc.). Melissa officinalis L. (lemon balm) has been traditionally used for decades with symptomatic benefits in patients with digestive disorders and could be a good candidate to reduce hyper-motility. However, the few studies carried out on this plant gave heterogeneous and contradictory results, depending mainly on the type of extracts tested and the gastrointestinal samples used. In our study, the basal and spasmolytic properties of an hydroethanolic extract of lemon balm leaves (CPSP-02; LC-MS characterized) were evaluated, in comparison with a vehicle, in vivo (2 days of oral administration; 1.14 mg/mice) and ex vivo (3 doses, 0.75, 2 and 4 mg/mL) on different parts of the GI tract from stomach to distal colon. CPSP-02 had no impact on metabolic parameters (body weight, food and water intake). No significant difference was observed in basal conditions between the two groups, vehicle and CPSP-02. However, in acetylcholine pre-contracted segments, the amplitude of contractions was significantly and specifically decreased in the upper digestive segments (stomach, duodenum and jejunum) with CPSP-02 both in vivo and ex vivo . A clear dose-dependent effect of CPSP-02 was also observed, where different concentrations exerted varying levels of impact across the GI segments. This study highlights the powerful antispasmodic effects of lemon balm CPSP-02 extract, with dose-dependent responses and GI segment-specific effects. The more precise mechanisms of action and the mediators involved remain to be determined. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Abot, A., Pomié, N., Berthomier, L., Cotte, C., Bardot, V., Guinobert, I., Blondeau, C., Holowacz, S., & Knauf, C. (2026). The impact of Melissa officinalis L. leaf extract CPSP-02 on gastrointestinal motility: Segmentspecific responses in a mouse model. Planta Medica, 92(03), 241. https://doi.org/10.1055/s-0045-1814974

Vancouver

Abot A, Pomié N, Berthomier L, Cotte C, Bardot V, Guinobert I, et al. The impact of Melissa officinalis L. leaf extract CPSP-02 on gastrointestinal motility: Segmentspecific responses in a mouse model. Planta Medica. 2026;92(03):241. doi:10.1055/s-0045-1814974

BibTeX
@article{Abot2026,
  author = {Abot, A and Pomié, N and Berthomier, L and Cotte, C and Bardot, V and Guinobert, I and Blondeau, C and Holowacz, S and Knauf, C},
  title = {The impact of Melissa officinalis L. leaf extract CPSP-02 on gastrointestinal motility: Segmentspecific responses in a mouse model},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {03},
  pages = {241},
  doi = {10.1055/s-0045-1814974}
}
Kostenlos starten →